G L Neil
About
In The Last Decade
G L Neil
41 papers receiving 779 citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 548
- Organic Chemistry 190
- Oncology 169
- Infectious Diseases 98
- Epidemiology 76
Countries citing papers authored by G L Neil
This map shows the geographic impact of G L Neil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G L Neil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G L Neil more than expected).
Fields of papers citing papers by G L Neil
This network shows the impact of papers produced by G L Neil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G L Neil. The network helps show where G L Neil may publish in the future.
Co-authorship network of co-authors of G L Neil
This figure shows the co-authorship network connecting the top 25 collaborators of G L Neil. A scholar is included among the top collaborators of G L Neil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G L Neil. G L Neil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 15 | |
| 4 | Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent. | 27 |
| 5 | 13 | |
| 6 | Pharmacology of 5'-esters of 1-beta-D-arabinofuranosylcytosine. | 8 |
| 7 | Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations. | 12 |
| 8 | Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine. | 10 |
| 9 | Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. | 20 |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 19 | |
| 13 | 2 | |
| 14 | The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors. | 23 |
| 15 | Cell-kill kinetics of several S-phase-specific drugs. | 84 |
| 16 | A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo. | 21 |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 9 | |
| 20 | Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice. | 27 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.